// App-Quantinova.ai

965 : Defining Cutoffs Corresponding to Low Levels of Disease Activity in Psoriatic Arthritis, Using the Patient-Reported Psoriatic Arthritis Impact of Disease Questionnaire (PsAID12). an Analysis of 436 Patients

Researchers

Presenter

  • Clemence Gorlier

Principal Investigators

  • Ana-Maria Orbai

  • Laura C. Coates

  • Uta Kiltz

  • Ying Ying Leung

  • Penelope Palominos

  • Juan D. Canete

  • Rossana Scrivo

  • Andra Rodica Balanescu

  • Emmanuelle Dernis

  • Sandra Talli

  • Adeline Ruyssen-Witrand

  • Martin Soubrier

  • Sibel Zehra Aydnn

  • Lihi Eder

  • Inna Gaydukova

  • Ennio Lubrano

  • Pascal Richette

  • M. Elaine Husni

  • Maarten de Wit

  • Josef S. Smolen

Medical Centers

  • Sorbonne Université, PARIS, France

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • University of Oxford, Oxford, United Kingdom

  • Rheumazentrum Ruhrgebiet, Herne, Germany

  • De- partment of Rheumatology and Immunology, Singapapore General Hospital, Singapore, Singapore

  • Rheumatology, Hospital de Clinicas de Porto Alegre, Santa Cecilia, Brazil

  • Rheumatology, Hospital Clinic and IDIBAPS, Barcelona, Spain

  • Department of Internal Medicine and Medical Disciplines, Sapienza University of Rome, Rome, Italy

  • Department of Internal Medicine and Rheumatology Sf. Maria Hospital, Bucharest, Romania

  • Service de Rhumatologie, CH du Mans, Le Mans, France

  • East-Tallinn Central Hospital, Department of Rheumatology, Tallinn, Estonia

  • Rheumatology, Purpan Hospital, Toulouse III University, Toulouse, France

  • Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France

  • University of Ottawa, Ottawa, ON, Canada

  • Women's College Research Institute, University of Toronto, Women's College Hospital, Toronto, ON, Canada

  • Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada

  • North-Western State Medical University n.a. I.I. Mechnikov, St. Petersburg, Russia

  • Dept. of Medicine and Health Science, University of Molise, Campobasso, Italy

  • Lariboisière Hospital, Lariboisière, University of Paris 7, Paris, France

  • Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH

  • Department of Medical Humanities, Amsterdam Public Health (APH), Amsterdam University Medical Centre, Amsterdam, Netherlands

  • Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

  • Rhumatologie, Médecine Sorbonne Université, Pitié-Salpétrière Hospital, Paris, France

Locations

  • France

  • United States

  • United Kingdom

  • Germany

  • Singapore

  • Brazil

  • Spain

  • Italy

  • Romania

  • Estonia

  • Canada

  • Russia

  • Netherlands

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A